Pancreatic Cancer Research

ResearcherCapital Medical UniversityNo recent work listed

Fei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6402-6811; OpenAlex author ID A5100325839. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper

Papers 3

  1. TMEM176A acts as a tumor suppressor gene in pancreatic cancer by inhibiting ERK signaling. Last author PMID 33593482↗
  2. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Last author DOI 10.1016/j.canlet.2018.10.039↗
  3. MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer. Last author DOI 10.1007/s12032-014-0418-5↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Feng Cao · 2 shared papers, 2019–2020 · strength 0.22
  2. Ang Li · 1 shared paper, 2020 · strength 0.13
  3. Yulin Guo · 1 shared paper, 2020 · strength 0.13
  4. Wentong Mei · 1 shared paper, 2019 · strength 0.10
  5. Yixuan Ding · 1 shared paper, 2019 · strength 0.10
  6. Yecheng Wang · 1 shared paper, 2019 · strength 0.10
  7. Chong-chong Gao · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.